Lynx1 Capital Management’s GH Research GHRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$357M Buy
13,263,288
+2,500,000
+23% +$52.2M 41.19% 1
2026
Q1
$151M Buy
10,763,288
+356,713
+3% +$5.48M 23.92% 2
2025
Q4
$132M Buy
10,406,575
+1,805,386
+21% +$24.6M 26.75% 2
2025
Q3
$104M Buy
8,601,189
+1,854,238
+27% +$25.9M 21.23% 3
2025
Q2
$82.2M Buy
6,746,951
+303,011
+5% +$3.32M 23.76% 2
2025
Q1
$71.1M Buy
6,443,940
+1,584,946
+33% +$17.7M 25.45% 1
2024
Q4
$34M Buy
4,858,994
+663,100
+16% +$5.33M 12.75% 3
2024
Q3
$28.1M Buy
4,195,894
+229,168
+6% +$2.35M 9.95% 4
2024
Q2
$46.3M Buy
3,966,726
+656,163
+20% +$7.88M 16.69% 3
2024
Q1
$35.3M Buy
3,310,563
+1,471,946
+80% +$11.7M 9.09% 6
2023
Q4
$10.7M Buy
1,838,617
+735,439
+67% +$5.19M 4.19% 8
2023
Q3
$11.1M Buy
1,103,178
+133,804
+14% +$1.55M 7.33% 6
2023
Q2
$11.5M Buy
+969,374
New +$9.94M 7.54% 6

Other funds holding GHRS

Lynx1 Capital Management's GHRS Position: Q2 2026 in Review

Lynx1 Capital Management increased its GH Research (GHRS) stake by 23% in Q2 2026, buying an estimated $52.2M and bringing the position to 13,263,288 shares worth $357M. The position accounts for 41.19% of the portfolio, ranked #1.

Lynx1 Capital Management first reported a position in GHRS in Q2 2023 and has held it in 13 quarters since. 63 funds tracked by Wall St. Rank hold GHRS as of Q2 2026.

  • Lynx1 Capital Management held 13,263,288 shares of GH Research worth $357M as of Q2 2026.
  • Lynx1 Capital Management bought 2,500,000 GH Research shares in Q2 2026, an estimated $52.2M.
  • GH Research made up 41.19% of Lynx1 Capital Management's portfolio in Q2 2026, its #1 holding.
  • Lynx1 Capital Management first reported a position in GH Research in Q2 2023 and has held it in 13 quarters since.
  • 63 funds tracked by Wall St. Rank held GH Research as of Q2 2026.

Based on Lynx1 Capital Management's 13F filing for Q2 2026, filed 12 Aug 2026.